Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study (Q37600494)

From Wikidata

Jump to navigation Jump to search

scientific article published on 08 January 2014

edit

Language	Label	Description	Also known as
English	Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study	scientific article published on 08 January 2014

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

retrieved

21 August 2017

title

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

retrieved

21 August 2017

main subject

multicenter clinical trial

0 references

lymphocyte

0 references

chemotherapy

1 reference

based on heuristic

inferred from title

breast cancer

1 reference

based on heuristic

inferred from title

triple-negative breast cancer

1 reference

based on heuristic

inferred from title

author

Maria Vittoria Dieci

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

Pierfranco Conte

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

Valentina Guarneri

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

Giuseppe Curigliano

series ordinal

10

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

Fabrice André

series ordinal

11

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

Suzette Delaloge

series ordinal

9

object named as

S Delaloge

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

author name string

C Criscitiello

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

A Goubar

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

G Viale

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

G Ficarra

series ordinal

7

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

M C Mathieu

series ordinal

8

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

publication date

8 January 2014

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

retrieved

21 August 2017

published in

Annals of Oncology

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

volume

25

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

issue

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

page(s)

611-618

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

cites work

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933248

retrieved

23 August 2017

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933248

retrieved

23 August 2017

Triple-negative breast cancer: clinical features and patterns of recurrence

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933248

retrieved

23 August 2017

Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933248

retrieved

6 September 2017

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933248

retrieved

1 September 2018

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933248

retrieved

1 September 2018

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3933248

retrieved

1 September 2018

Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24401929

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24401929

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathological complete response and accelerated drug approval in early breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24401929

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1093/ANNONC/MDT556

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

Fatcat ID

release_7rwqzvayrraixk4mmc7vq6y4he

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/7rwqzvayrraixk4mmc7vq6y4he

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

3933248

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

PubMed publication ID

24401929

1 reference

stated in

Europe PubMed Central

PMC publication ID

3933248

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24401929%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 May 2020

ResearchGate publication ID

259630239

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37600494&oldid=2229523644"